期刊文献+

人细胞色素P450 4A11基因核心启动子区的鉴定 被引量:1

The cloning and characterization of CYP4A11 gene promoter region
下载PDF
导出
摘要 目的研究细胞色素P450 4A11基因启动子区对该基因转录活性的影响。方法运用生物信息学的方法预测细胞色素P450 4A11基因启动子区的重要调控序列,然后采用5’侧翼区缺失的方法将包含重要调控序列的启动子克隆到双报告基因载体中,用脂质体转染HepG2细胞,24h后检测荧光素酶相对活性。然后使用Alibaba2.0 Transfac4.0预测增强子区域可能存在的转录因子结合位点。结果·36~-720~+1、-972~+1、-1039~+1区域的启动子活性较高,其中-972~+1区域最强,与此相比-536~+1、-720~+1荧光素酶相对活性分别下降了96.9%和70.1%。结论人CYP4A11基因5’侧翼区的影响转录活性的启动子关键区域位于-972~-720bp范围内。 Objective Cytochrome P450 4A11 ( CYP4A11 ) may play an important role in the regulation of blood pressure via its metabolites 19/20-Hydroxyeicosatetraenoic acids (20-HETE) and the present study identified the promoter sequence and 5' -flanking region of CYP4A11 gene and investigated the molecular mechanisms through which regulates the expression of CYP4A11 gene . Method To functional analysis of CYP4A11 promoter in HepG2 ceils, Luciferase reporter plasmids containing vector alone ( pGL3-Basic ) and serially truncated putative CYP4A11 promoter fragments (1641bp-536 kb ) which were clone based on the prediction of onlinesoftware of UCSC , were transiently transfected into HepG2 ceils. Furthermore, we investigated potential transcription factor binding sites in the region fuctions as an ellhancer using the prediction programs Transfac4.0. Results The highest level of CYP4A11 promoter activity was exhibited by the - 972bp promoter construct. Reducing the promoter length by 252 bp (-720bp promoter construct) and further 184 bp (-536bp promoter construct) caused a significant decrease in activity, by 70. 1% and 96.9% in HepG2 ceils, respectively (P 〈 0.001 ). Conclution These data indicate that positive regulatory elements may locate in the regions from -972 to -536bp of the CYP4A11 gene.
出处 《中国分子心脏病学杂志》 CAS 2008年第1期28-33,共6页 Molecular Cardiology of China
基金 国家自然科学基金(N0.30470712) 湖北省自然基金(2006ABAl27)资助
关键词 细胞色素P450 4A11 启动子 转录 荧光素酶 CYP450-dA11 Promoter Transcription Dual-Luciferase assay
  • 相关文献

参考文献14

  • 1[1]LaskerJM,Chen WB,Wolf I,et al.Formation of 20-hydroxyeicosatetraenoic acid,a vasoactive and nstriuretic eicosanoid,in human kideny.Role of Cyp4F2 and Cyp4A11.J Biol Chem,2000,275:4118-4126.
  • 2[2]Kawashima H,Naganuma T,Kusanose E,et al.Human fattyacidomega-hydroxylase,CYP4A011:determination of complete genomid sequence and characterization of purifed recombinant protein.Arch Biochem Biophys,2003,78:333-339.
  • 3[3]Crespi CL,Chang TK,Waxman DJ.Detemianation of CYP4A11-catalyzed lauric acid 12-hydroxylation by high-perfomance liquid chromatography with radiometric detection.Methods Mol Biol,1998,107:163-167.
  • 4[4]Alonso-Galacia M,Maier KG,Greene AS,et al.Role of 20-hydroxyeicosatertraenoic acid in thr renal and vasoconstrictor actions of angloptonsin Ⅱ.Am.J Physiol Regul lntegr Comp Physiol,2002,283:R60-68.
  • 5[5]Cho BH,Park BL,Kim LH,et al.Highly polymorphic human CYP4A11 gene.J Hum GeneS,2005,50:259-263.
  • 6[6]Oyekan AO,McGiff JC.Functional response of the rat kidney to inhibition of nitric oxide synthesis:role of cytochrome p450-derived arachidonate metabolites.Br J Pharmacol,1998,125:1065-1073.
  • 7[7]Bellamine A,Wang Y,Waterman MR,et al.Characterization of the CYP4A11 gene,a second CYP4A gene in humans.Arch Biochem Biophys,2003,409:221-227.
  • 8[8]Yu M,Alonso-Galicia M,Sun CW,et al.20-hydroxyeicosatetraenoic acid(20-HETE):structural determinanats for renal vasoconstriction.Bioorg Med Chem,2003,11:2803-2821.
  • 9[9]Roman RJ,Maier KG,Sun CW,et al.Renal and cadiovascular actions of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids.Clin Exp Pharmacol Physiol,2002,7:855-865.
  • 10[10]Takeuehi K,Miyata N,Renic M,et al.Hemoglobin,NO,and 20-HETE interactions in mediating cerebral vasoconstriction following SAH.Am J Physiol Regul Integr Comp Physiol,2006,290:R84-89.

同被引文献28

  • 1Zordoky BN,El-Kadi AO.Effect of cytochrome P450 polymor-phism on arachidonic acid metabolism and their impact on cardio-vascular diseases[J].Pharmacol Ther,2010;125:446-463.
  • 2Bellamine A,Wang Y,Waterman MR,et al.Characterization ofthe CYP4A11 gene,a second CYP4A gene in humans[J].ArchBiochem Biophys,2003;409:221-227.
  • 3Imaoka S,Ogawa H,Kimura S,et al.Complete cDNA sequenceand cDNA-directed expression of CYP4Al1,a fatty acid omega-hydroxylase expressed in human kidney[J].DNA Cell Boil,1993;12:893-899.
  • 4Sugimoto K,Akasaka H,Katsuya T,et al.A polymorphism regu-lates CYP4A11 transcriptional activity and is associated with hyper-tension in a Japanese population[J].J Hypertens,2008;52:1142-1148.
  • 5Zhang R,Lu J,Hu C,et al.A common polymorphism ofCYP4A11 is associated with blood pressure in a Chinese population[J].J Hypertens Res,2011;34:645-648.
  • 6Ding H,Cui G,Zhang L,et al.Association of common variants ofCYP4A11 and CYP4F2 with stroke in the Han Chinese population[J].Pharmacogenet Genomics,2010;20:187-194.
  • 7Gainer JV,Lipkowitz MS,Yu C,et al.Association of a CYP4A11variant and blood pressure in black men[J].J Am Soc Nephrol,2008;19:1606-1612.
  • 8Fu Z,Nakayama T,Sato N,et al.Ahaplotype of the CYP4A11gene associated with essential hypertension in Japanese men[J].JHypertens,2008;26:453-461.
  • 9Mayer B,Lieb W,Gotz A,et al.Association of the 8590T>C pol-ymorphism of CYP4A11 with hypertension in the Monica Augsburgechocardiographic substudy[J].J Hypertens,2005;46:766-771.
  • 10Ward NC,Tsai IJ,Barden A,et al.A single nucleotide polymor-phism in the CYP4F2 but not CYP4A11 gene is associated with in-creased 20-hete excretion and blood pressure[J].J Hypertens,2008;51:1393-398.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部